All In Biotech

Drug Trial Radar · NCT07172919

A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation

A Rollover Study of Sotorasib With or Without Panitumumab for the Treatment of Cancer Subjects With KRAS p.G12C Mutation Previously Treated in an Amgen-Sponsored Study

Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

14

Planned (sponsor's estimate)

Start

Jan 2, 2026

Primary completion

Jul 1, 2028

Study completion Jul 1, 2028

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
First posted
Sep 15, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of the study is to evaluate the safety and tolerability of the continuation of sotorasib with or without panitumumab and/or other anti-cancer therapies in participants continuing to derive benefit in Amgen-sponsored protocols.

Conditions

  • Advanced Solid Tumors

Interventions

  • SotorasibDrug

    Sotorasib will be administered orally as a tablet.

  • PanitumumabDrug

    Panitumumab will be administered as an IV infusion.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants with Treatment-Emergent Adverse Events (TEAEs)Time frame: Up to approximately 18 months

Locations

13 sites in 9 countries. Site status is shown where the registry gives one.

  • Florida Cancer Specialists - Fort Myers

    Fort Myers, Florida · Recruiting

  • University of Texas MD Anderson Cancer Center

    Houston, Texas · Recruiting

  • Scientia Clinical Research Ltd

    Randwick, New South Wales, Australia · Terminated

  • Centre Leon Berard

    Lyon, France · Recruiting

  • Evangelische Lungenklinik

    Berlin, Germany · Recruiting

  • Universitaetsklinikum Koln

    Cologne, Germany · Recruiting

  • Henry Dunant Hospital Center

    Athens, Greece · Recruiting

  • Theagenion Cancer Hospital

    Thessaloniki, Greece · Recruiting

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    Roma, Italy · Recruiting

  • Aichi Cancer Center

    Nagoya, Aichi-ken, Japan · Recruiting

  • National Hospital Organization Hokkaido Cancer Center

    Sapporo, Hokkaido, Japan · Terminated

  • Universitaetsspital Basel

    Basel, Switzerland · Recruiting

  • Taichung Veterans General Hospital

    Taichung, Taiwan · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.